Focus Stocks
Approaching Resistance - E*TRADE
Published on Wednesday, 08 February 2012 05:40 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of E*TRADE Financial Corporation (NASDAQ:ETFC) are trading very close to calculated resistance at $9.33 with the current price action closing at just $9.10 placing the stock near levels that make it difficult to buy.
E*TRADE Financial Corporation (NASDAQ:ETFC) provides online brokerage and related products and services primarily to individual retail investors. The company offers investor-focused banking, primarily sweep deposits and savings products.
E*TRADE's current stock range is defined by current calculated support defined at $7.77 and by the resistance level at $9.33, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for E*TRADE, as the stock is well above support, however, as the stock pulls back towards $7.77 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $9.33 then traders will get an opportunity to enter E*TRADE stock by establishing a position as the stock moves to a higher range.
Related Articles
- Approaching Support: E*TRADE
- E*TRADE Financial Corporation Reports Monthly Activity for April 2012
- Trading Idea: Is E*TRADE Breaking Down?
- Is E*TRADE Close to Support?
- E*TRADE Financial Corporation Announces Results of Annual Meeting of Stockholders
- Trading Idea: What to Expect with E*TRADE Breaking Support
- E*TRADE near Support
- Is E*TRADE Expecting Resistance?
- E*TRADE Is Between the 50 and 200 Day Moving Averages
Related Partner Headlines
- E*Trade Financial Corp (ETFC): Today's Featured Financial Services Winner - TheStreet.com
- Pump Up the Volume - TheStreet.com
- No Longer Seeing Green: E*Trade Financial in a Transitional Phase - Benzinga
- ISI Reiterates Hold Rating on E*Trade Following Management Meeting - Benzinga
- E*TRADE Financial Corporation Reports Monthly Activity for January 2012; DARTs up 20% MoM - Benzinga
- E*TRADE Financial Appoints Rodger A. Lawson and Rebecca Saeger to Board of Directors - Benzinga
- Kass: A Contrarian's Dream - TheStreet.com
- E*TRADE Financial Appoints Frank J. Petrilli Chairman of the Board - Benzinga
- E*Trade Financial Stock Falls On Unusually High Volume (ETFC) - TheStreet.com
- SanDisk, Netflix: After-Hours Trading - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









